Related Experiment Videos
Transcranial magnetic stimulation downregulates beta-adrenoreceptors in rat cortex
A Fleischmann1, A Sternheim, A M Etgen
1Department of Neuroscience, Albert Einstein College of Medicine, Bronx, NY, USA.
Journal of Neural Transmission (Vienna, Austria : 1996)
|January 1, 1996
Summary
Transcranial magnetic stimulation (TMS) in rats reduced beta-adrenergic receptor binding, similar to antidepressant treatments. This suggests TMS is a potential new therapy for depression.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Transcranial magnetic stimulation (TMS) is a non-invasive brain stimulation technique.
- Neurochemical and behavioral effects of TMS are increasingly being studied.
- Antidepressant treatments often target beta-adrenergic receptor systems.
Purpose of the Study:
- To investigate the neurochemical effects of TMS in a rat model.
- To compare TMS effects to established antidepressant treatments.
Main Methods:
- Rats underwent a 9-day course of repeated transcranial magnetic stimulation (TMS).
- Beta-adrenergic receptor binding in cortical tissue was measured.
Main Results:
- Repeated TMS significantly reduced beta-adrenergic receptor binding in the cortex.
- This reduction was comparable to effects observed with electroconvulsive shock (ECS) and other antidepressant therapies.
Conclusions:
- TMS induces neurochemical changes in the brain that are consistent with antidepressant action.
- TMS shows potential as a novel therapeutic strategy for treating depression.